XPR1 as A Potential Drug Target for Neurological Disorders (G9213)

Target Name: XPR1

NCBI ID: G9213

XPR1

XPR1 as A Potential Drug Target for Neurological Disorders

XPR1 (X3) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and muscle. It is a key regulator of the blood-brain barrier, which is a critical barrier that helps to protect the brain from harmful substances.

XPR1 has been shown to play a key role in the development and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. It has also been linked to the development of certain cancer types.

One of the most promising aspects of XPR1 is its potential as a drug target. Researchers have identified several potential drug targets for XPR1, including those that target its role in the blood-brain barrier and its role in the development of certain neurological diseases.

XPR1 has been shown to play a key role in the regulation of the blood-brain barrier, which is a critical barrier that helps to protect the brain from harmful substances. The blood-brain barrier is made up of several different cell types, including neurons and glial cells, which are responsible for maintaining the integrity of the brain.

XPR1 helps to regulate the movement of these cells through the blood-brain barrier, allowing certain substances to come into the brain while keeping others out. This is important for maintaining the health and function of the brain.

Research has also shown that XPR1 is involved in the development and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. These conditions are characterized by the progressive loss of brain cells and the development of hallmark symptoms, such as difficulty with thinking, memory, and movement.

XPR1 has also been linked to the development of certain cancer types, including neuroblastoma, a type of cancer that is most commonly found in children.

One of the most promising aspects of XPR1 is its potential as a drug target. Researchers have identified several potential drug targets for XPR1, including those that target its role in the blood-brain barrier and its role in the development of certain neurological diseases.

One potential drug target for XPR1 is the interaction between XPR1 and the protein PDGF-BB. PDGF-BB is a protein that is involved in the development and maintenance of the blood-brain barrier, and XPR1 has been shown to interact with it.

Research has shown that the interaction between XPR1 and PDGF-BB is important for the development of the blood-brain barrier and for the regulation of the brain.

Another potential drug target for XPR1 is the interaction between XPR1 and the protein NF-kappa-B. NF-kappa-B is a protein that is involved in the regulation of various cellular processes, including inflammation and cell growth.

Research has shown that the interaction between XPR1 and NF-kappa-B is important for the regulation of the blood-brain barrier and for the development of certain neurological diseases.

In addition to these potential drug targets, researchers are also exploring the use of XPR1 as a biomarker for the diagnosis and progression of certain neurological diseases.

One approach to using XPR1 as a biomarker is to measure the levels of XPR1 in brain tissue or blood samples from patients with certain neurological conditions. This can be done using techniques such as Western blotting or Western blotting.

Research has shown that the levels of XPR1 in brain tissue or blood samples from patients with Alzheimer's disease, Parkinson's disease, and multiple sclerosis are significantly decreased compared to the levels of these proteins in healthy brain tissue or blood samples.

This suggests that XPR1 may be a useful biomarker for the diagnosis and

Protein Name: Xenotropic And Polytropic Retrovirus Receptor 1

Functions: Plays a role in phosphate homeostasis. Mediates phosphate export from the cell (PubMed:23791524, PubMed:25938945). Binds inositol hexakisphosphate (Ins6P) and similar inositol polyphosphates, such as 5-diphospho-inositol pentakisphosphate (5-InsP7); these are important intracellular signaling molecules (PubMed:27080106)

The "XPR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XPR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets